跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,599 条关于
“Leaps by Bayer”
全部
64,599
临床试验
28,358
药物
485
机构
716
资讯
35,040
去年
Duke-NUS Receives $1.5M to Advance AI-Powered Antifibrotic Drug Discovery Platform
6个月前
Immunitas Therapeutics to Present First-in-Human Data for Novel Anti-CD161 Antibody IMT-009 at AACR 2026
去年
Indapta Therapeutics Raises $22.5 Million to Advance NK Cell Therapy
2个月前
Celea Therapeutics Secures $180 Million to Launch First Head-to-Head Phase 3 Trial of Deupirfenidone in IPF
去年
Nuvig Therapeutics Secures $161 Million to Advance Novel Immunomodulatory Therapies
8个月前
Bayer Expands Genetic Medicine Portfolio Through Strategic siRNA and AI Partnerships
去年
Immunitas Therapeutics Unveils Promising Preclinical Data for First-in-Class Anti-CD161 Antibody IMT-380 in Autoimmune Diseases
去年
Senti Bio Reports Promising Early Results for Gene Circuit CAR-NK Cell Therapy in Relapsed/Refractory AML
去年
FDA Rejects Astellas' Izervay Update; Cytokinetics and Bayer Announce Aficamten Licensing Deal
2年前
EMA Approves Pre-filled Syringe for Eylea 8 mg, Enhancing AMD and DME Treatment
第 1 页,共 3504 页
上一页
下一页